The Discounted Cash Flow (DCF) valuation of Theravance Biopharma Inc (TBPH) is 18.47 USD. With the latest stock price at 17.05 USD, the upside of Theravance Biopharma Inc based on DCF is 8.3%.
Based on the latest price of 17.05 USD and our DCF valuation, Theravance Biopharma Inc (TBPH) is a buy. buying TBPH stocks now will result in a potential gain of 8.3%.
| Range | Selected | |
| WACC / Discount Rate | 7.4% - 9.5% | 8.5% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 14.88 - 26.98 | 18.47 |
| Upside | -12.7% - 58.2% | 8.3% |